Home › Overweight › Arizona › Chandler
Overweight clinical trials in Chandler, AZ
4 studies for Overweight are looking for participants at sites in and around Chandler (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Chandler
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Arizona Clinical Trials, Chandler
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Chandler
- Steatotic Liver Disease10 studies
- Non-Small Cell Lung Cancer5 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Digestive Diseases5 studies
- Obesity5 studies
- Metastatic Cancer4 studies
- Type 2 Diabetes4 studies
- Liver Diseases4 studies
- Cirrhosis3 studies
- Alzheimer's Disease3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.